Specialized Disclosure Report (sd)
May 25 2017 - 3:04PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________
FORM SD
Specialized Disclosure Report
____________________________
NEVRO CORP.
(Exact name of registrant as specified in its charter)
____________________________
|
|
|
|
|
Delaware
|
|
001-36715
|
|
56-2568057
|
(State or other jurisdiction
of incorporation or organization)
|
|
(Commission
File Number)
|
|
(IRS employer
Identification No.)
|
|
|
|
1800 Bridge Parkway, Redwood City, CA
|
|
94065
|
(Address of principal executive offices)
|
|
(Zip code)
|
Andrew Galligan
Chief Financial Officer
(650) 251-0005
____________________________
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
☒
Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2016.
Section 1—Conflict Minerals Disclosure
Item 1.01 Conflict Minerals Disclosure and Report
This Specialized Disclosure Report on Form SD (“Form SD”) of Nevro Corp. (“Nevro”) is filed pursuant to Rule 13p-1 promulgated under the Securities Exchange Act of 1934 for the reporting period of January 1, 2016 to December 31, 2016.
A copy of Nevro’s Conflict Minerals Report is provided as Exhibit 1.01 to this Form SD, is hereby incorporated by reference herein, and is publicly available at http://www.nevro.com/English/About-Us/Corporate-Governance/default.aspx.
Item 1.02 Exhibit
As specified in Section 2, Item 2.01 of this Form SD, Nevro is hereby filing its Conflict Minerals Report as Exhibit 1.01.
Section 2—Exhibits
Item 2.01 Exhibits
Exhibit No.
|
|
Description
|
|
|
|
|
1.01
|
|
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form SD.
|
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
NEVRO CORP.
|
|
|
|
|
|
|
|
|
By:
|
/s/ Andrew Galligan
|
|
Date:
|
May 25, 2017
|
|
|
|
|
|
|
Andrew Galligan
|
|
|
|
|
Chief Financial Officer
|
|
|
|
3
Nevro (NYSE:NVRO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nevro (NYSE:NVRO)
Historical Stock Chart
From Apr 2023 to Apr 2024